Latest filing published 14 Dec 2018 for GENEREX BIOTECHNOLOGY CORP, €272.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Harold Gray Haines: trading record in brief
Harold Gray Haines appears in our data through filings on Generex Biotechnology Corp shares, published by SEC (Form 4). The record holds 4 filings, for trades running from 4 December 2018 to 7 December 2018.
No open-market sale appears; the market trades are 4 purchases worth €10k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The median purchase comes to €1,395. None of the 4 purchases we analysed coincided with buying by another insider of the same company within 30 days.
On 14 December 2018 came the latest disclosure, an open-market purchase for €272 in Generex Biotechnology Corp. Typically, a trade is published a median of 9 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Harold Gray Haines
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 300 shares@ US$1.032.6% of flowCommon StockSEC:0001761913-18-000001:0Canonical exit: 7 Mar 2019 (T+90)
- 8,000 shares@ US$1.0570.7% of flowCommon StockSEC:0001761913-18-000001:1Canonical exit: 7 Mar 2019 (T+90)
- 555 shares@ US$2.109.8% of flowCommon StockSEC:0001761913-18-000002:0Canonical exit: 4 Mar 2019 (T+90)
- 945 shares@ US$2.1216.9% of flowCommon StockSEC:0001761913-18-000002:1Canonical exit: 4 Mar 2019 (T+90)
4 of 4 declarations